Phreesia, Inc. (NYSE:PHR) COO Sells $48,159.30 in Stock

Phreesia, Inc. (NYSE:PHR) COO Evan Roberts sold 1,785 shares of the stock in a transaction on Wednesday, January 15th. The shares were sold at an average price of $26.98, for a total value of $48,159.30. Following the completion of the transaction, the chief operating officer now owns 768,208 shares of the company’s stock, valued at $20,726,251.84. This trade represents a 0.23 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Evan Roberts also recently made the following trade(s):

• On Wednesday, January 8th, Evan Roberts sold 2,681 shares of Phreesia stock. The shares were sold at an average price of $27.95, for a total transaction of $74,933.95.
• On Monday, January 6th, Evan Roberts sold 2,873 shares of Phreesia stock. The stock was sold at an average price of $26.61, for a total transaction of $76,450.53.

Phreesia Trading Up 1.6 %

Shares of NYSE PHR opened at $27.24 on Friday. The business has a 50 day simple moving average of $23.42 and a 200 day simple moving average of $22.77. Phreesia, Inc. has a 52 week low of $17.07 and a 52 week high of $29.16. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.74 and a quick ratio of 1.74.

Phreesia (NYSE:PHR) last posted its earnings results on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, topping the consensus estimate of ($0.29) by $0.04. The firm had revenue of $106.80 million during the quarter, compared to analyst estimates of $106.33 million. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The company’s revenue for the quarter was up 16.6% on a year-over-year basis. During the same period in the previous year, the company earned ($0.58) EPS. As a group, sell-side analysts forecast that Phreesia, Inc. will post -1.1 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the stock. Truist Financial raised their price objective on shares of Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a research note on Wednesday, December 11th. KeyCorp raised their target price on Phreesia from $28.00 to $30.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 8th. Needham & Company LLC reissued a “buy” rating and set a $29.00 price target on shares of Phreesia in a research report on Friday, January 10th. Citigroup raised their price objective on Phreesia from $31.00 to $35.00 and gave the stock a “buy” rating in a research report on Friday, January 10th. Finally, Robert W. Baird dropped their target price on Phreesia from $34.00 to $30.00 and set an “outperform” rating on the stock in a report on Wednesday, December 11th. Twelve analysts have rated the stock with a buy rating, According to MarketBeat, the company has an average rating of “Buy” and a consensus target price of $31.00.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of PHR. Trust Point Inc. lifted its position in Phreesia by 3.5% during the 3rd quarter. Trust Point Inc. now owns 17,887 shares of the company’s stock worth $408,000 after acquiring an additional 607 shares during the last quarter. Ensign Peak Advisors Inc increased its stake in shares of Phreesia by 3.2% in the second quarter. Ensign Peak Advisors Inc now owns 22,491 shares of the company’s stock worth $477,000 after purchasing an additional 700 shares during the period. Rhumbline Advisers lifted its position in shares of Phreesia by 1.0% during the 2nd quarter. Rhumbline Advisers now owns 82,136 shares of the company’s stock worth $1,741,000 after purchasing an additional 853 shares during the last quarter. The Manufacturers Life Insurance Company boosted its stake in Phreesia by 3.3% during the 3rd quarter. The Manufacturers Life Insurance Company now owns 27,935 shares of the company’s stock valued at $637,000 after purchasing an additional 905 shares during the period. Finally, MetLife Investment Management LLC grew its holdings in Phreesia by 3.8% in the 3rd quarter. MetLife Investment Management LLC now owns 30,781 shares of the company’s stock valued at $701,000 after buying an additional 1,120 shares during the last quarter. 92.10% of the stock is currently owned by institutional investors and hedge funds.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.